BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26569228)

  • 1. Colorectal cancer treatment using bacteria: focus on molecular mechanisms.
    Ebrahimzadeh S; Ahangari H; Soleimanian A; Hosseini K; Ebrahimi V; Ghasemnejad T; Soofiyani SR; Tarhriz V; Eyvazi S
    BMC Microbiol; 2021 Jul; 21(1):218. PubMed ID: 34281519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Delivery Approaches for the Treatment of Cervical Cancer.
    Ordikhani F; Erdem Arslan M; Marcelo R; Sahin I; Grigsby P; Schwarz JK; Azab AK
    Pharmaceutics; 2016 Jul; 8(3):. PubMed ID: 27447664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomedical applications of stimuli-responsive "smart" interpenetrating polymer network hydrogels.
    Wu J; Xue W; Yun Z; Liu Q; Sun X
    Mater Today Bio; 2024 Apr; 25():100998. PubMed ID: 38390342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy.
    Bádon ES; Beke L; Mokánszki A; András C; Méhes G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma.
    Yuan Q; Zhang W; Shang W
    Front Endocrinol (Lausanne); 2022; 13():1045167. PubMed ID: 36518255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2.
    Lachat C; Boyer-Guittaut M; Peixoto P; Hervouet E
    Epigenomes; 2018 Dec; 3(1):. PubMed ID: 34991274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements.
    Lee SH; Bajracharya R; Min JY; Han JW; Park BJ; Han HK
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31952340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA, a novel target biomolecule, is involved in the progression of colorectal cancer.
    Sun W; Ren S; Li R; Zhang Q; Song H
    Am J Cancer Res; 2019; 9(11):2515-2530. PubMed ID: 31815050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jiedu Sangen Decoction Inhibits the Invasion and Metastasis of Colorectal Cancer Cells by Regulating EMT through the Hippo Signaling Pathway.
    Yuan L; Zhou M; Wasan HS; Zhang K; Li Z; Guo K; Shen F; Shen M; Ruan S
    Evid Based Complement Alternat Med; 2019; 2019():1431726. PubMed ID: 31341488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon targeted beads loaded with pterostilbene: Formulation, optimization, characterization and
    Ansari M; Sadarani B; Majumdar A
    Saudi Pharm J; 2019 Jan; 27(1):71-81. PubMed ID: 30662309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.
    Riaz MK; Riaz MA; Zhang X; Lin C; Wong KH; Chen X; Zhang G; Lu A; Yang Z
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29315231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of ELMO3 Suppresses Growth, Invasion and Metastasis of Colorectal Cancer.
    Peng HY; Yu QF; Shen W; Guo CM; Li Z; Zhou XY; Zhou NJ; Min WP; Gao D
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
    Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
    Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy.
    Lin C; Ng HL; Pan W; Chen H; Zhang G; Bian Z; Lu A; Yang Z
    Int J Mol Sci; 2015 Nov; 16(11):26936-52. PubMed ID: 26569228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting into the colon: approaches to target colorectal cancer.
    Patel MM
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1343-50. PubMed ID: 24898947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.
    Krishnaiah YS; Khan MA
    Pharm Dev Technol; 2012; 17(5):521-40. PubMed ID: 22681390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight to drug delivery aspects for colorectal cancer.
    Gulbake A; Jain A; Jain A; Jain A; Jain SK
    World J Gastroenterol; 2016 Jan; 22(2):582-99. PubMed ID: 26811609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
    Grifantini R; Taranta M; Gherardini L; Naldi I; Parri M; Grandi A; Giannetti A; Tombelli S; Lucarini G; Ricotti L; Campagnoli S; De Camilli E; Pelosi G; Baldini F; Menciassi A; Viale G; Pileri P; Cinti C
    J Control Release; 2018 Jun; 280():76-86. PubMed ID: 29733876
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.